New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
LifeMD, Inc.
LFMD
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

202M

Medical - Pharmaceuticals

Next Earning date - 13 Nov 2024

202M

Medical - Pharmaceuticals

Next Earning date - 13 Nov 2024

4.68USD
Shape0.10 ( 2.18%)
favorite-chart

Relative Strenght

98
favorite-chart

Volume Buzz

-30%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

64%

Quote Panel

Shape
Updated October 20, 2024
1W 0.86 % 1M -8.59 % 3M -32.66 % 1Y -29.84 %

Key Metrics

Shape
  • Market Cap

    201.56M


  • Shares Outstanding

    43.07M


  • Share in Float

    34.09M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    4.68


  • Average Volume

    495065


  • Beta

    1.186


  • Range

    4.1-12.88


  • Industry

    Medical - Pharmaceuticals


  • Website

    https://www.lifemd.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.13x

P/S Ratio

-45.95x

P/B Ratio

-4.4

Debt/Equity

-13.2%

Net Margin

$-0.7

EPS

How LFMD compares to sector?

P/E Ratio

Relative Strength

Shape

LFMD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$255M

Shape404%

2025-Revenue

$0.04

Shape76%

2025-EPS

$105M

Shape-2518%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

KeyBanc

initialise

Previous: Not converted

2024-06-04

Now: Overweight

Cantor Fitzgerald

initialise

Previous: Not converted

2023-07-21

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.03
vs -0.36

Q4.22

arrow
arrow

+107%

0.02
vs -0.29

Q1.23

arrow
arrow

N/A

-0.15
vs -0.25

Q2.23

arrow
arrow

N/A

-0.23
vs -0.22

Q3.23

arrow
arrow

N/A

-0.20
vs -0.03

Q4.23

arrow
arrow

N/A

-0.12
vs 0.02

Q1.24

arrow
arrow

N/A

-0.19
vs -0.15

Q2.24

arrow
arrow

N/A

-0.19
vs -0.23

Q3.24

arrow
arrow

N/A

-0.12
vs -0.20

Q4.24

arrow
arrow

N/A

-0.04
vs -0.12

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+26%

31.4M  vs 24.9M

Q4.22

arrow
arrow

+3%

28.1M  vs 27.4M

Q1.23

arrow
arrow

+14%

33.1M  vs 29M

Q2.23

arrow
arrow

+18%

35.9M  vs 30.5M

Q3.23

arrow
arrow

+23%

38.6M  vs 31.4M

Q4.23

arrow
arrow

+60%

44.9M  vs 28.1M

Q1.24

arrow
arrow

+33%

44.1M  vs 33.1M

Q2.24

arrow
arrow

+41%

50.7M  vs 35.9M

Q3.24

arrow
arrow

+39%

53.8M  vs 38.6M

Q4.24

arrow
arrow

+28%

57.3M  vs 44.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-217%

-2.17
vs -1.67

Q4.22

arrow
arrow

+169%

1.69
vs -2.17

Q1.23

arrow
arrow

+138%

1.38
vs 1.69

Q2.23

arrow
arrow

+61%

0.61
vs 1.38

Q3.23

arrow
arrow

+48%

0.48
vs 0.61

Q4.23

arrow
arrow

-106%

-1.06
vs 0.48

Q1.24

arrow
arrow

+801%

8.01
vs -1.06

Q2.24

arrow
arrow

+163%

1.63
vs 8.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

44

44
vs 43

2%

Q4.22

arrow
arrow

47

47
vs 44

7%

Q1.23

arrow
arrow

46

46
vs 47

-2%

Q2.23

arrow
arrow

57

57
vs 46

24%

Q3.23

arrow
arrow

66

66
vs 57

16%

Q4.23

arrow
arrow

90

90
vs 66

36%

Q1.24

arrow
arrow

96

96
vs 90

7%

Q2.24

arrow
arrow

108

108
vs 96

13%

Earnings Growth

Latest News

LFMD

globenewswire.com

16 hours ago